BEYRIZO Trademark

Trademark Overview


On Monday, March 28, 2022, a trademark application was filed for BEYRIZO with the United States Patent and Trademark Office. The USPTO has given the BEYRIZO trademark a serial number of 97333961. The federal status of this trademark filing is REGISTERED as of Tuesday, May 23, 2023. This trademark is owned by Takeda Pharmaceuticals International AG. The BEYRIZO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for use in the field of neuroscience, namely, for the treatment of neurological and nervous system diseases and disorders; pharmaceutical preparations for the treatment of seizures associated with Dravet Syndrome and Lennox-Gastaut Syndrome
beyrizo

General Information


Serial Number97333961
Word MarkBEYRIZO
Filing DateMonday, March 28, 2022
Status700 - REGISTERED
Status DateTuesday, May 23, 2023
Registration Number7059515
Registration DateTuesday, May 23, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 7, 2023

Trademark Statements


Goods and ServicesPharmaceutical products for use in the field of neuroscience, namely, for the treatment of neurological and nervous system diseases and disorders; pharmaceutical preparations for the treatment of seizures associated with Dravet Syndrome and Lennox-Gastaut Syndrome

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 31, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTakeda Pharmaceuticals International AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGlattpark-Opfikon 8152
CH

Party NameTakeda Pharmaceuticals International AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGlattpark-Opfikon 8152
CH

Party NameTakeda Pharmaceuticals International AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGlattpark-Opfikon 8152
CH

Trademark Events


Event DateEvent Description
Tuesday, May 23, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 23, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, March 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 7, 2023PUBLISHED FOR OPPOSITION
Wednesday, February 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 31, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 31, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, January 31, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 31, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, January 31, 2023EXAMINERS AMENDMENT -WRITTEN
Saturday, January 14, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 13, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 13, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 27, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 27, 2022NON-FINAL ACTION E-MAILED
Tuesday, September 27, 2022NON-FINAL ACTION WRITTEN
Tuesday, September 27, 2022ASSIGNED TO EXAMINER
Wednesday, August 24, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, April 1, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 31, 2022NEW APPLICATION ENTERED